https://www.selleckchem.com/products/blu-667.html
The worsening of renal function after the start of valsartan therapy is relatively common in clinical practice. However, few data are available on the incidence of worsening renal function after the beginning of therapy with sacubitril/valsartan. We retrospectively enrolled 202 outpatients with HFrEF that started therapy with sacubitril/valsartan to evaluate the prevalence of worsening renal function and its clinical significance. At 1 month, a worsening renal function (defined as 20% decrease in eGFR occurring after 1 month of AR
Gefällt mir
Kommentar
Teilen
